ABVC BioPharma(ABVC) - 2025 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-40700 ABVC BioPharma, Inc. (Exact name of Company in its charter) | Nevada | 26-0014658 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or orga ...